Can the NIH replace all private sector clinical R&D?

A paper by Proudman et al. (2024) finds that doing so would be extremely expensive. Including all preclinical, clinical and post-approval R&D activities, total annual costs to maintain the average lifecycle level of 49.4 approved drugs across all disease areas during the 2018–22 period was estimated to be $139.6 billion. Including only pre-launch costs, total…

Read More

The Status of Abortion-related State Ballot Initiatives Since Dobbs

Last updated on March 24, 2026 Since the Supreme Court’s Dobbs decision, overturning Roe v. Wade, voters in 17 states have weighed in on ballot measures regarding abortion– some more than once. In November 2026, voters in Missouri, Nevada, and Virginia will weigh in on abortion measures that could change the legal status of abortion in their state. In addition, measures in Idaho and Nebraska are in the process of collecting signatures.

Read More

Links

Mental health from remote educational instruction.Halloween health tips.“Dreamers” and ACA plan eligibility.Using muons to ‘x-ray’ the pyramids of Egypt.A Milwaukee legend.

Read More

4 Execs’ Wishes for a Better Healthcare Future

At DiMe’s Healthcare 2030 Summit, four healthcare leaders shared the innovations they believe could most improve care, from AI-driven solutions to reduce medical errors to stronger primary care relationships that could save billions. The post 4 Execs’ Wishes for a Better Healthcare Future appeared first on MedCity News.

Read More